91470-28-9

Basic information

• Product Name: 2-Furamide,tetrahydro-(6CI,7CI)
• Synonyms: 2-Furamide,tetrahydro-(6CI,7CI);Tetrahydrofuran-2-carboxaMide;tetrahydro-2-Furancarboxamide;Tetrahydro-furan-2-carboxylic acid amide
• CAS NO: 91470-28-9
• Molecular Formula: C₅H₉NO₂
• Molecular Weight: 115.13046
• Product Categories: AMIDE
• Mol File: 91470-28-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Furamide,tetrahydro-(6CI,7CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Furamide,tetrahydro-(6CI,7CI)(91470-28-9)
• EPA Substance Registry System: 2-Furamide,tetrahydro-(6CI,7CI)(91470-28-9)

Safety Data

• Hazardous Substances Data: 91470-28-9(Hazardous Substances Data)

Usage

General Description

2-Furamide, tetrahydro, also known as 2-furantetrahydramide, is a chemical compound with the molecular formula C5H9NO2. It is a cyclic amide with a tetrahydrofuran ring and a furan ring. 2-Furamide,tetrahydro-(6CI,7CI) is used in the synthesis of pharmaceuticals and other organic compounds. Its unique structure and reactivity make it a valuable building block in organic chemistry. Additionally, it has potential applications in the field of agrochemicals and materials science. Further research into the properties and reactivity of 2-furamide, tetrahydro could reveal new potential uses and applications for this compound.

Upstream product

• 609-38-1 furan-2-carboxylic acid amide 
• 16874-34-3 ethyl tetrahydrofurancarboxylate 
• 16874-33-2 tetrahydro-2-furancarboxylic acid 
• 541-41-3 chloroformic acid ethyl ester 

Downstream Products

• 619329-27-0 tetrahydro-2-furancarboximidamide hydrochloride 
• 688000-41-1 tetrahydrofuran-2-carboximidamide 
• 14631-43-7 2-tetrahydrofuran-2-carbonitrile 
• 1615-70-9 penta-2,4-dienenitrile 
• 1191-99-7 2,3-dihydro-2H-furan 

Relevant articles and documents

Macrocyclic MCL-1 inhibitors and methods of use

The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).

Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; The identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor

Heteroalicyclic carboxamidines were synthesised and evaluated as inhibitors of nitric oxide synthases. (2R)-2-Pyrrolidinecarboxamidine, in particular, was shown to be a highly potent in vitro (IC50 = 0.12 μM) and selective iNOS inhibitor (>100-fold vs both eNOS and nNOS), with probable binding to the key anchoring glutamate residue and co-ordination to the haem iron.

ALPHA SUBSTITUTED CARBOXYLIC ACID AS PPAR MODULATORS

Alpha substituted carboxylic acids of formula (I): wherein R' and R2 are as defined in the specification and R3 is A) formula (II); B) formula (III); C) formula (IV); and D) formula (V); wherein Y, Art, Are, AP, R4, R5, R6, R7, R6, R9, R9a, R10, R", R12, R17, ring A, and p are as defined in the specification; pharmaceutical compositions containing effective amounts of said compounds or their salts are useful for treating PPAR, specifically PPAR α/y related disorders, such as diabetes, dyslipidemia, obesity and inflammatory disorders.